These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35384391)

  • 1. Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient.
    Bloom PP; Donlan J; Torres Soto M; Daidone M; Hohmann E; Chung RT
    Hepatol Commun; 2022 Aug; 6(8):2079-2089. PubMed ID: 35384391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
    Bajaj JS; Kassam Z; Fagan A; Gavis EA; Liu E; Cox IJ; Kheradman R; Heuman D; Wang J; Gurry T; Williams R; Sikaroodi M; Fuchs M; Alm E; John B; Thacker LR; Riva A; Smith M; Taylor-Robinson SD; Gillevet PM
    Hepatology; 2017 Dec; 66(6):1727-1738. PubMed ID: 28586116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Bajaj JS; Salzman NH; Acharya C; Sterling RK; White MB; Gavis EA; Fagan A; Hayward M; Holtz ML; Matherly S; Lee H; Osman M; Siddiqui MS; Fuchs M; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2019 Nov; 70(5):1690-1703. PubMed ID: 31038755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.
    Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L
    Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.
    Madsen M; Kimer N; Bendtsen F; Petersen AM
    Scand J Gastroenterol; 2021 May; 56(5):560-569. PubMed ID: 33840331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
    Bajaj JS; Gavis EA; Fagan A; Wade JB; Thacker LR; Fuchs M; Patel S; Davis B; Meador J; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2021 May; 73(5):1688-1700. PubMed ID: 32750174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
    Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
    Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients.
    Allegretti JR; Kassam Z; Mullish BH; Chiang A; Carrellas M; Hurtado J; Marchesi JR; McDonald JAK; Pechlivanis A; Barker GF; Miguéns Blanco J; Garcia-Perez I; Wong WF; Gerardin Y; Silverstein M; Kennedy K; Thompson C
    Clin Gastroenterol Hepatol; 2020 Apr; 18(4):855-863.e2. PubMed ID: 31301451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time series strain tracking analysis post fecal transplantation identifies individual specific patterns of fecal dominant donor, recipient, and unrelated microbial strains.
    Koo H; Morrow CD
    PLoS One; 2022; 17(9):e0274633. PubMed ID: 36107983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
    Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series.
    Mehta R; Kabrawala M; Nandwani S; Kalra P; Patel C; Desai P; Parekh K
    Indian J Gastroenterol; 2018 Nov; 37(6):559-562. PubMed ID: 30474827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis.
    Tun KM; Hong AS; Batra K; Naga Y; Ohning G
    Cureus; 2022 May; 14(5):e25537. PubMed ID: 35800791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation results in bacterial strain displacement in patients with inflammatory bowel diseases.
    Zou M; Jie Z; Cui B; Wang H; Feng Q; Zou Y; Zhang X; Yang H; Wang J; Zhang F; Jia H
    FEBS Open Bio; 2020 Jan; 10(1):41-55. PubMed ID: 31622538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Aroniadis OC; Brandt LJ; Oneto C; Feuerstadt P; Sherman A; Wolkoff AW; Kassam Z; Sadovsky RG; Elliott RJ; Budree S; Kim M; Keller MJ
    Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):675-685. PubMed ID: 31326345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and gut microbiota analysis of severe alcohol-associated hepatitis patients undergoing healthy donor fecal transplant or pentoxifylline therapy: single-center experience from Kerala.
    Philips CA; Ahamed R; Rajesh S; Singh S; Tharakan A; Abduljaleel JK; Augustine P
    Gastroenterol Rep (Oxf); 2022; 10():goac074. PubMed ID: 36479155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.